ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for in vivo efficacy against SARS-CoV-2.
Jenna Kelly DickDustin HicksVenkatramana D KrishnaJules A SangalaBenjamin T ZandstraCarly A BaehrJ Sjef VerbeekMark S CraggMaxim C-J CheeranMarco PravetoniGeoffrey Thomas HartPublished in: bioRxiv : the preprint server for biology (2024)
clearance of two disparate SARS-CoV-2 variants.